It's that time of year again: the dreaded cold and flu season is on the horizon. But lurking in the shadows is a more ...

Even though cooler days may seem far off, now is the best time to plan ahead for a healthy winter. One common respiratory ...

Respiratory syncytial virus (RSV) vaccination in adults aged 60 years and older may be cost-effective in preventing illness, ...

Medical risk-based approaches outperformed age-based strategies, even when vaccine prices were low, the study authors said.

Often dismissed as just another common cold, RSV can be deadly, especially for infants and older people. Hannah and her twin ...

Targeting vaccination programs for respiratory syncytial virus (RSV) to older adults with underlying health conditions is a cost-effective way to reduce disease, according to a new modelling study in ...

Most people experience mild RSV reinfections throughout their lifetime, particularly during respiratory virus season (November to March in Canada). People are at higher risk if they are older than 75 ...

A UPMC pulmonologist talks about the symptoms, explains who is most at risk for a severe infection, and tells us how ...

Covid-19 levels in the United States are high and rising, flu season is approaching quickly and RSV cases are already ...

All flu vaccines for the 2024-25 season will be trivalent, meaning they protect against three different strains of influenza: ...

(RSV) is a common cause of lower respiratory tract infection (LRTI) and is responsible for a high burden of hospital admission and mortality in children. RSV–LRTI is also associated with long-term ...

Background: Respiratory syncytial virus (RSV) vaccines could reduce disease burden and costs in older Canadian adults, but vaccination program cost-effectiveness is unknown. We evaluated the ...